drugset / Trial / NCT07599605

Prophylaxis Against Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis.

NCT07599605

RandomizedParallel-groupOpen-labelPrevention

Summary

Endoscopic retrograde cholangiopancreatography (ERCP) is a key procedure for managing biliopancreatic diseases, although it is associated with complications such as post-ERCP pancreatitis. This study assessed the efficacy of a prophylactic protocol combining rectal indomethacin with aggressive hydration to reduce the incidence of post-ERCP pancreatitis and serum amylase and lipase levels.

Timeline

Start
2024-03-04
Primary completion
2024-12-27
Completion
2025-01-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Indomethacin Small molecule 100 mg

Indications